About Me

My photo
Archana Kapoor Nagpal is an internationally published author of four books. She often participates in the short story competitions, and her winning stories are now part of international anthologies. She has seen her short stories, poems and Haiku published in other anthologies as well She has also been actively involved in the editing, proofreading and book designing of various anthologies. You can read more about her writing career at the below link: https://www.facebook.com/archanaknagpal/

Thursday, December 30, 2010

Aspirin - Willow Tree Extracts

I read about Aspirin today on MSN. Since I am on something similar medication I thought to read and know more about Willow Tree Extracts. I thought to share this article. For my friends on FB, I have already shared the article link.
I am using the content of the article for my readers so that you do not miss on this. It might be useful for someone out there. This is my post under ‘From My Library’. Please this is just to read and know about Aspirin as a useful drug.
Aspirin has been humanity's wonder drug. Extracts from the willow tree have been used for pain relief in folk medicine since the time of the ancient Greeks. By 1897 a synthetic derivative (acetyl salicylic acid) of the plant's active ingredient (salicin) was created. This allowed aspirin to become the most widely used medicine in the world.
In recent years its benefits as a blood-thinning drug have led to it being prescribed in low doses of around 50mg to reduce deaths from stroke and heart attack. There were also hints that aspirin may help prevent some cancers. But these were mostly based on observational studies, which can be misleading.
The gold standard of scientific evidence is the randomised controlled trial, preferably one with a lot of peo ple and held over a long time. The results of just such a trial, published in the Lancet, suggest that aspirin is indeed an astonishing drug. Peter Rothwell at the John Radcliffe Hospital in Oxford and his colleagues looked at deaths due to cancers during and after randomised trials of daily aspirin. The trials had actually been started to look at how useful aspirin was for preventing heart attacks and strokes. Nevertheless, the data from the 25,570 patients enrolled in eight trials was also revealing about cancer.
In trials lasting between four and eight years, the patients who had been given aspirin were 21% less likely to die from cancer than those who had been given a placebo. These results were based on 674 cancer deaths, so are unlikely to represent the kind of statistical oddity that can beset studies on cancer risks that sometimes create headlines.